Department of Advanced Biomedical Sciences, Neuroradiology Unit, University “Federico II”, Via S. Pansini 5, Naples, 80131, Italy
IRCCS SDN, Naples, Italy
Department of Neurosciences Reproductive and Odonto-stomatological Sciences, University “Federico II”, Naples, Italy
Institute of Biostructure and Bioimaging, National Research Council, Naples, Italy
References: Kanda, T., Ishii, K., Kawaguchi, H., Kitajima, K., Takenaka, D., High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: Relationship with increasing cumulative dose of a gadolinium-based contrast material (2014) Radiology, 270, pp. 834-84
Kanda, T., Oba, H., Toyoda, K., Kitajima, K., Furui, S., Brain gadolinium deposition after administration of gadolinium-based contrast agents (2016) Jpn J Radiol, 34, pp. 3-9
Ramalho, J., Semelka, R.C., Ramalho, M., Nunes, R.H., Alobaidy, M., Castillo, M., Gadolinium-based contrast agent accumulation and toxicity: An update (2016) Am J Neuroradiol, 37, pp. 1192-1198
Radbruch, A., Are some agents less likely to deposit gadolinium in the brain? (2016) Magn Reson Imaging, 34, pp. 1351-1354
Kanda, T., Osawa, M., Oba, H., High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: Association with linear versus macrocyclic gadolinium chelate administration (2015) Radiology, 275, pp. 803-809
Kanda, T., Fukusato, T., Matsuda, M., Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: Evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy (2015) Radiology, 276, pp. 228-232
McDonald, R.J., McDonald, J.S., Kallmes, D.F., Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging (2015) Radiology, 275, pp. 772-782
Khant, Z.A., Hirai, T., Kadota, Y., T1 shortening in the cerebral cortex after multiple administrations of gadolinium-based contrast agents (2017) Magn Reson Med Sci, 16, pp. 84-86
Cao, Y., Huang, D.Q., Shih, G., Prince, M.R., Signal change in the dentate nucleus on T1-weighted MR images after multiple administrations of gadopentetate dimeglumine versus gadobutrol (2016) Am J Roentgenol, 206, pp. 414-419
Jost, G., Lenhard, D.C., Sieber, M.A., Lohrke, J., Frenzel, T., Pietsch, H., Signal increase on unenhanced T1-weighted images in the rat brain after repeated, extended doses of gadolinium-based contrast agents: Comparison of linear and macrocyclic agents (2016) Invest Radiol, 51, pp. 83-89
Radbruch, A., Weberling, L.D., Kieslich, P.J., High-signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: Evaluation of the macrocyclic gadolinium-based contrast agent gadobutrol (2015) Invest Radiol, 50, pp. 805-810
Stojanov, D.A., Aracki-Trenkic, A., Vojinovic, S., Benedeto-Stojanov, D., Ljubisavljevic, S., Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: Correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol (2016) Eur Radiol, 26, pp. 807-815
Murata, N., Gonzalez-Cuyar, L.F., Murata, K., Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: Preliminary results from 9 patients with normal renal function (2016) Invest Radiol, 51, pp. 447-453
Palma, G., Tedeschi, E., Borrelli, P., A novel multiparametric approach to 3D quantitative MRI of the brain (2015) Plos One, 10
Kuno, H., Jara, H., Buch, K., Qureshi, M.M., Chapman, M.N., Sakai, O., Global and regional brain assessment with quantitative MR imaging in patients with prior exposure to linear gadolinium-based contrast agents (2016) Radiology, 31
Tedeschi, E., Palma, G., Canna, A., In vivo dentate nucleus MRI relaxometry correlates with previous administration of gadolinium-based contrast agents (2016) Eur Radiol, 26, pp. 4577-4584
Cheng, H.L., Stikov, N., Ghugre, N.R., Wright, G.A., Practical medical applications of quantitative MR relaxometry (2012) J Magn Reson Imaging, 36, pp. 805-824
Kromrey, M.L., Liedtke, K.R., Ittermann, T., Intravenous injection of gadobutrol in an epidemiological study group did not lead to a difference in relative signal intensities of certain brain structures after 5 years (2017) Eur Radiol, 27, pp. 772-777
Schlemm, L., Chien, C., Bellmann-Strobl, J., Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients (2016) Mult Scler, p. 27. , 1352458516670738. [Epub ahead of print]
Radbruch, A., Haase, R., Kieslich, P.J., No signal intensity increase in the dentate nucleus on unenhanced T1-weighted MR images after more than 20 serial injections of macrocyclic gadolinium-based contrast agents (2016) Radiology, 7. , [Epub ahead of print]
Robert, P., Violas, X., Grand, S., Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats (2016) Invest Radiol, 51, pp. 73-82
Aime, S., Caravan, P., Biodistribution of gadolinium-based contrast agents, including gadolinium deposition (2009) J Magn Reson Imaging, 30, pp. 1259-1267
Longitudinal assessment of dentate nuclei relaxometry during massive gadobutrol exposure